Trial Profile
Phase II Open-Label Trial of Ipilimumab for Metastatic Merkel Cell Carcinoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 19 May 2017
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Merkel cell carcinoma
- Focus Therapeutic Use
- 11 Aug 2013 New trial record